PC
NEO icon

Pier Capital’s NeoGenomics NEO Stock Holding History

Pier Capital’s Portfolio NEO Stock Details NEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-534,311
Closed -$4.3M – 131
2016
Q2 		$4.3M Buy
534,311
+9,743
+2% +$78.1K 0.78% 82
2016
Q1 		$3.54M Sell
524,568
-48,723
-8% -$321K 0.68% 85
2015
Q4 		$4.51M Buy
+573,291
New +$4.2M 0.78% 76

Other funds holding NEO

GE
General Electric Evendale, Ohio $308M AUM 40.86% 1-Year Est. Return
NCGI
Next Century Growth Investors Plymouth, Minnesota $1.38B AUM 102.34% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
EA
Emerald Acquisition Seattle, Washington $51.8B AUM
CRC
Curi RMB Capital Chicago, Illinois $5.62B AUM 18.93% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Pier Capital's NEO Position: Q3 2016 in Review

Pier Capital sold out of NeoGenomics (NEO) in Q3 2016, closing a stake of 534,311 shares — an estimated $4.3M sold.

Pier Capital first reported a position in NEO in Q4 2015 and held it in 3 quarters. The position peaked at $4.51M in Q4 2015. 137 funds tracked by Wall St. Rank hold NEO as of Q3 2016.

  • Pier Capital reported no remaining NeoGenomics position as of Q3 2016 after selling out during the quarter.
  • Pier Capital sold 534,311 NeoGenomics shares in Q3 2016, an estimated $4.3M.
  • Pier Capital first reported a position in NeoGenomics in Q4 2015 and held it in 3 quarters.
  • Pier Capital's NeoGenomics position peaked at $4.51M in Q4 2015.
  • 137 funds tracked by Wall St. Rank held NeoGenomics as of Q3 2016.

Based on Pier Capital's 13F filing for Q3 2016, filed 14 Nov 2016.